Description
In this episode, Kris and Paul discuss two papers that try to clear up the rumors surrounding one of the most popular supplements in sports nutrition:
International Society of Sports Nutrition Position Stand: Safety and Efficacy of Creatine Supplementation in Exercise, Sport, and Medicine
authored by Richard B. Kreider, Douglas S. Kalman, Jose Antonio, Tim N. Ziegenfuss, Robert Wildman, Rick Collins, Darren G. Candow, Susan M. Kleiner, Anthony L. Almada, and Hector L. Lopez; published in the Journal of the International Society of Sports Nutrition in 2017.
And:
Common Questions and Misconceptions About Creatine Supplementation: What Does the Scientific Evidence Really Show?
authored by Jose Antonio, Darren G. Candow, Scott C. Forbes, Bruno Gualano, Andrew R. Jagim, Richard B. Kreider, Eric S. Rawson, Abbie E. Smith-Ryan, Trisha A. VanDusseldorp, Darryn S. Willoughby, and Tim N. Ziegenfuss; published in the Journal of the International Society of Sports Nutrition in 2021.
They’ll attempt to determine whether or not creatine really is the secret to getting swole, or if it’s just going to cause your kidneys to eventually fail. Tune in to find out if all those Olympians in the early ’90’s were really on to something, or just angling to get on GNC’s payroll.
New episodes drop on Wednesdays. Make sure you’re subscribed, leave us a review, and share!
And please tell all of your friends who cite those 1982 studies that say you'll look like a bodybuilder if you use creatine, not that that's necessarily a bad thing, that you have the perfect podcast for them.
Breaking Beta is brought to you by Power Company Climbing and Crux Conditioning, and is a proud member of the Plug Tone Audio Collective. Find full episode transcripts, citations, and more at our website.
Follow Kris and Breaking Beta on Instagram
Follow Paul and Crux Conditioning on Instagram
If you have questions, comments, or want to suggest a paper we should cover, find us at our Community + Knowledge Hub.
Our music is from legendary South Dakota band Rifflord.